- Home
- MIST vs TNYA Comparison
MIST vs TNYA Comparison
Compare MIST & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | TNYA |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 157.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | MIST | TNYA |
|---|---|---|
| Price | $1.70 | $0.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $8.50 | $5.25 |
| AVG Volume (30 Days) | 2.1M | ★ 4.2M |
| Earning Date | 03-12-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.63 | $0.36 |
| 52 Week High | $3.06 | $2.35 |
Technical Indicators
Market Signals| Indicator | MIST | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 34.51 | 40.89 |
| Support Level | $1.70 | $0.65 |
| Resistance Level | $1.89 | $0.86 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.86 | 7.67 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.